𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of hepatitis C related thrombocytopenia with interferon alpha

✍ Scribed by Sandeep Rajan; Howard A. Liebman

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
85 KB
Volume
68
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of hepatitis C: Re-treatment wit
Therapy of hepatitis C: Re-treatment with alpha interferon
✍ A Alberti; L Chemello; F Noventa; L Cavalletto; GianLuca De Salvo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

The long-term benefit of interferon therapy in chronic hepatitis C is limited. During therapy, serum alanine aminotransferase (ALT) levels decrease to normal and hepatitis C virus (HCV) RNA decreases in 40% to 60% of patients. However, most patients relapse after therapy withdrawal, so that no more

Treatment of chronic hepatitis C by cont
Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha
✍ Dr. Vicente Carreño; Luis Tapia; Jean-Charles Ryff; Juan Antonio Quiroga; Inmacu 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

## Abstract The effectiveness of a daily continuous infusion of interferon‐alpha was evaluated in 12 patients (10 males, 2 females; mean age of 33 years, range 19–62) with biopsy‐proven chronic active hepatitis C. Nine million units (MU) of recombinant interferon‐alpha 2A (rIFN‐α 2A) were administe

Blunted thrombopoietin response to inter
Blunted thrombopoietin response to interferon alfa–induced thrombocytopenia during treatment for hepatitis C
✍ Markus Peck-Radosavljevic; Martina Wichlas; Johann Pidlich; Paul Sims; Gloria Me 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Thrombocytopenia is common in advanced-stage liver disease and is partly caused by inadequate thrombopoietin (TPO) production in the failing liver. Treatment of chronic hepatitis C with interferon alfa (IFN-␣) often induces thrombocytopenia, sometimes even leading to discontinuation of treatment. TP

Therapy of hepatitis C: Alpha interferon
Therapy of hepatitis C: Alpha interferon and ribavirin
✍ O Reichard; R Schvarcz; O Weiland 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Ribavirin is a nucleoside analogue that has been evaluated as a therapy of chronic hepatitis C alone and in combination with alpha interferon. Ribavirin is well absorbed orally and is typically given in doses of 1,000 to 1,200 mg/d. Three randomized, placebo-controlled studies comprising more than 1

Pleural effusion associated with pegylat
Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C
✍ Amit Arora; Leonardo Vargas; Tomasz J. Kuzniar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52‐year‐old woman, who developed pneumonitis with exudative, lymphocytic‐predominant pleural effusion following